These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10731297)

  • 1. Pharmacologic therapies in the treatment of peripheral vascular disease: clinical experience with reteplase, a third-generation thrombolytic.
    Laird JR
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():27B-32B. PubMed ID: 10731297
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolytic and antiplatelet therapy in peripheral vascular disease with use of reteplase and/or abciximab. The SCVIR Consultants' Conference; May 22, 2000; Orlando, FL. Society for Cardiovascular and Interventional Radiology.
    Benenati J; Shlansky-Goldberg R; Meglin A; Seidl E;
    J Vasc Interv Radiol; 2001 Jul; 12(7):795-805. PubMed ID: 11435535
    [No Abstract]   [Full Text] [Related]  

  • 3. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.
    Ouriel K; Katzen B; Mewissen M; Flick P; Clair DG; Benenati J; McNamara TO; Gibbens D
    J Vasc Interv Radiol; 2000; 11(7):849-54. PubMed ID: 10928520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reteplase: nursing implications for catheter-directed thrombolytic therapy for peripheral vascular occlusions.
    Bussard ME
    Crit Care Nurse; 2002 Jun; 22(3):57-63. PubMed ID: 12092294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia and early reperfusion therapy.
    Tanne D; Schwammenthal Y
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12733513
    [No Abstract]   [Full Text] [Related]  

  • 6. Splenic rupture: an additional complication of thrombolytic therapy.
    Summers JB
    Crit Care Nurse; 2002 Oct; 22(5):18-9; author reply 19-20. PubMed ID: 12382613
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolving strategies for thrombolytic therapy of peripheral vascular occlusion.
    Valji K
    J Vasc Interv Radiol; 2000 Apr; 11(4):411-20. PubMed ID: 10787198
    [No Abstract]   [Full Text] [Related]  

  • 8. Intra-arterial reteplase for the treatment of acute limb ischemia.
    Laird JR; Dangas G; Jaff M; Satler LF; Mehran R; Leon MB
    J Invasive Cardiol; 1999 Dec; 11(12):757-62. PubMed ID: 10745480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reteplase (Retavase).
    Med Lett Drugs Ther; 1997 Feb; 39(995):17-8. PubMed ID: 9057777
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolytic therapy and the impact of medication errors.
    Weinstock B
    J Invasive Cardiol; 2004 Sep; Suppl():10-4. PubMed ID: 23573664
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy evaluation of reteplase in a novel canine acute pulmonary thromboembolism model developed by minimally invasive surgery and digital subtraction angiography.
    Zhang Y; Liu H; Zhang Y; Wu Q; Zhang Y; Zhang J; Zhou X; Jiao H; Fan F; Xue Q; Wang X; Zhong Z
    Drug Des Devel Ther; 2018; 12():3717-3730. PubMed ID: 30464403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The results of arterial thrombolysis.
    Kroese AJ; Staxrud LE
    Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078
    [No Abstract]   [Full Text] [Related]  

  • 13. Intra-arterial prourokinase for acute ischemic stroke.
    Akins PT
    JAMA; 2000 Apr; 283(16):2102; author reply 2103-4. PubMed ID: 10791495
    [No Abstract]   [Full Text] [Related]  

  • 14. [Increased efficacy of thrombolytic therapy in acute myocardial infarction by improved properties of new thrombolytic agents].
    Huber K
    Wien Klin Wochenschr; 2000 Sep; 112(17):742-8. PubMed ID: 11042902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tenecteplase in peripheral embolic disease.
    Bannerjee AK; Dastidar DG
    Indian Heart J; 2010; 62(4):313-5. PubMed ID: 21280470
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombolysis in capsular warning syndrome].
    González Hernández A; Fabre Pi O; López Fernández JC; Díaz Nicolás S
    Med Clin (Barc); 2010 May; 134(13):612-3. PubMed ID: 19359006
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous tissue plasminogen activator in central retinal artery occlusion.
    Falavarjani KG; Modarres M
    Am J Ophthalmol; 2009 Jun; 147(6):1105; author reply 1105-6. PubMed ID: 19463547
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteplase (Cathflo Activase).
    Middleton G; Ruzevick B
    Clin J Oncol Nurs; 2004 Aug; 8(4):417-8, 420. PubMed ID: 15354930
    [No Abstract]   [Full Text] [Related]  

  • 19. Using mismatch on MRI to select thrombolytic responders: an attractive hypothesis awaiting confirmation.
    Davis SM; Donnan GA
    Stroke; 2005 May; 36(5):1106-7. PubMed ID: 15802638
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled trials comparing reteplase with alteplase and streptokinase in patients with acute myocardial infarction.
    Amsterdam EA
    Pharmacotherapy; 1996; 16(5 Pt 2):137S-140S. PubMed ID: 8888101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.